Woman scientist in lab 20
  • News and more from the frontiers of medicine


AVXS-101 Managed Access Program

Letter from AveXis to the SMA community.

Read More

Novartis @ J.P Morgan 2020

Novartis is attending the J.P Morgan Healthcare Conference in San Francisco from January 13th to January 16th.

This is the largest and most inspiring conference for our industry.

Learn More

Accelerating our digital transformation with Amazon Web Services (AWS)

We are collaborating with AWS to build an enterprise-wide data and analytics platform to help transform business operations, starting with the way medicines are manufactured and delivered.

Learn More

Behind the research driving our data

Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.

Learn More

New cell and gene facility inaugurated in Switzerland

Novartis opens facility for innovative cell and gene therapies at our Stein manufacturing site in the canton of Aargau.

Learn More

Novartis Financial Results – Q3 2019

Novartis announced the company’s financial results for the third quarter of 2019.

Read More

  • Media Library

    Browse and download multimedia resources including images, videos, infographics and more.

  • Novartis Annual Review 2018

    Novartis Annual Review 2018

    The Annual Review, our new corporate report, explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2018.

  • A healthcare professional speaks to a patient

    Corporate Responsibility

    Learn more about our Corporate Responsibility strategy and access resources including the annual Novartis in Society Report

  • Corporate Fact sheets

    Corporate Fact Sheets

    The fact sheets provide a comprehensive overview of Novartis overall as well as our divisions and our research organization. It also outlines our commitment to associates and to corporate responsibility.

Social media
Media contacts

Find contacts at Novartis for media and journalist inquiries from the general and individual contacts listed below.

AveXis data integrity

Novartis stands behind Zolgensma® for the treatment of children less than 2 years of age with spinal muscular atrophy.